Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of HDL-Cholesterol Levels

Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of... Translational Science Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of HDL-Cholesterol Levels Elise F. Villard, Petra EI Khoury, Eric Frisdal, Eric Bruckert, Karine Clement, Dominique Bonnefont-Rousselot, Randa Bittar, Wilfried Le Goff, Maryse Guerin Objective—We investigated the impact of several genetic variants located in genes encoding for proteins involved in biogenesis, maturation, and intravascular remodeling of high density lipoprotein (HDL) particles on plasma efflux capacity. Approach and Results—The capacity of whole-plasma to mediate cholesterol efflux from cholesterol-loaded human THP-1 macrophages was measured in 846 individuals (450 men and 396 women). We demonstrated that rs17231506 (CETP c.– 1337 C>T), rs2230806 (ABCA1 p.R219K), rs1799837 (APOA1 c.–75 G>A), rs5086 (APOAII c.–265 T>C), and rs1800588 (LIPC c.–514 C>T) single nucleotide polymorphisms (SNPs) significantly modulate the capacity of whole-plasma to mediate cholesterol efflux from human macrophages in a sex-dependent manner. Such associations were independent of circulating plasma lipid levels (HDL-cholesterol, triglyceride, low density lipoprotein-cholesterol). In women, we identified the APOA1 c.–75 G>A and the LIPC c.–514 C>T variants as major contributors of interindividual variability of plasma efflux capacity, whereas the ABCA1 p.R219K and the APOAII c.–265 T>C SNPs mostly contribute to total variance of plasma efflux capacity in men. Multiple regression http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis, Thrombosis, and Vascular Biology Wolters Kluwer Health

Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of HDL-Cholesterol Levels

Loading next page...
 
/lp/wolters-kluwer-health/genetic-determination-of-plasma-cholesterol-efflux-capacity-is-gender-TYjtFlMIZ9

References (52)

Copyright
© 2013 American Heart Association, Inc.
ISSN
1079-5642
eISSN
1524-4636
DOI
10.1161/ATVBAHA.112.300979
pmid
23372063
Publisher site
See Article on Publisher Site

Abstract

Translational Science Genetic Determination of Plasma Cholesterol Efflux Capacity Is Gender-Specific and Independent of HDL-Cholesterol Levels Elise F. Villard, Petra EI Khoury, Eric Frisdal, Eric Bruckert, Karine Clement, Dominique Bonnefont-Rousselot, Randa Bittar, Wilfried Le Goff, Maryse Guerin Objective—We investigated the impact of several genetic variants located in genes encoding for proteins involved in biogenesis, maturation, and intravascular remodeling of high density lipoprotein (HDL) particles on plasma efflux capacity. Approach and Results—The capacity of whole-plasma to mediate cholesterol efflux from cholesterol-loaded human THP-1 macrophages was measured in 846 individuals (450 men and 396 women). We demonstrated that rs17231506 (CETP c.– 1337 C>T), rs2230806 (ABCA1 p.R219K), rs1799837 (APOA1 c.–75 G>A), rs5086 (APOAII c.–265 T>C), and rs1800588 (LIPC c.–514 C>T) single nucleotide polymorphisms (SNPs) significantly modulate the capacity of whole-plasma to mediate cholesterol efflux from human macrophages in a sex-dependent manner. Such associations were independent of circulating plasma lipid levels (HDL-cholesterol, triglyceride, low density lipoprotein-cholesterol). In women, we identified the APOA1 c.–75 G>A and the LIPC c.–514 C>T variants as major contributors of interindividual variability of plasma efflux capacity, whereas the ABCA1 p.R219K and the APOAII c.–265 T>C SNPs mostly contribute to total variance of plasma efflux capacity in men. Multiple regression

Journal

Arteriosclerosis, Thrombosis, and Vascular BiologyWolters Kluwer Health

Published: Apr 1, 2013

There are no references for this article.